Fannin Innovation Studio

About The Fund

Fannin Innovation Studio is a specialized early-stage life sciences development group that focuses on the commercialization of groundbreaking innovations originating from institutions in the Texas Medical Center. The firm addresses the commercialization gap in Houston by forming strategic partnerships with the city's top-tier higher education institutions, and it operates by co-founding and meticulously managing startup companies. They in-license promising, early-stage therapeutic and medical device technologies, developing these assets meticulously through the preclinical stages and into early clinical trials. Their approach combines seed capital provisioning, ensuring central office space, and leveraging a vast network of resources to nurture startups. Fannin Innovation Studio is recognized for creating vital products and catalyzing a sustainable life sciences entrepreneurship ecosystem both locally and nationally. With their strong entrepreneurial know-how and a team of managers with diverse business backgrounds and commercialization experience, they aim at de-risking technologies to address vital unmet medical needs. Notably, their approach includes unconventional development processes and a robust training component, with an apprenticeship program that has trained over 300 interns and fellows, equipping new generations of entrepreneurs with hands-on experience in leading portfolio companies from innovation to successful commercialization. This commitment to entrepreneurial talent development is highlighted by testimonials from key medical institutions like Baylor College of Medicine and MD Anderson Cancer Center. Their pipeline features an array of programs, and they have raised over $242 million through grant and investor funding, evidencing their efficacy in asset development and contributing to the life sciences industry.